Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.304 $0.440 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $0.304 $0.532
52 weeks $0.250 $1.09

Historical Clene Inc. prices

Date Open High Low Close Volume
Feb 27, 2024 $0.427 $0.430 $0.415 $0.425 818 651
Feb 26, 2024 $0.440 $0.440 $0.420 $0.427 889 793
Feb 23, 2024 $0.450 $0.450 $0.418 $0.430 1 062 685
Feb 22, 2024 $0.460 $0.468 $0.411 $0.430 1 418 169
Feb 21, 2024 $0.460 $0.464 $0.445 $0.450 289 412
Feb 20, 2024 $0.479 $0.484 $0.434 $0.461 589 387
Feb 16, 2024 $0.460 $0.470 $0.450 $0.460 588 094
Feb 15, 2024 $0.480 $0.480 $0.450 $0.460 399 294
Feb 14, 2024 $0.500 $0.532 $0.450 $0.465 1 575 908
Feb 13, 2024 $0.428 $0.520 $0.387 $0.423 1 864 655
Feb 12, 2024 $0.436 $0.436 $0.405 $0.420 258 614
Feb 09, 2024 $0.384 $0.440 $0.360 $0.425 574 178
Feb 08, 2024 $0.437 $0.440 $0.410 $0.418 357 163
Feb 07, 2024 $0.430 $0.449 $0.421 $0.440 265 656
Feb 06, 2024 $0.452 $0.474 $0.440 $0.450 219 478
Feb 05, 2024 $0.460 $0.468 $0.415 $0.440 409 843
Feb 02, 2024 $0.467 $0.480 $0.387 $0.469 931 810
Feb 01, 2024 $0.490 $0.490 $0.446 $0.480 710 860
Jan 31, 2024 $0.520 $0.533 $0.490 $0.494 376 787
Jan 30, 2024 $0.520 $0.538 $0.501 $0.520 273 738
Jan 29, 2024 $0.530 $0.532 $0.488 $0.515 373 632
Jan 26, 2024 $0.530 $0.550 $0.513 $0.528 434 980
Jan 25, 2024 $0.519 $0.540 $0.480 $0.530 435 320
Jan 24, 2024 $0.473 $0.516 $0.473 $0.510 911 236
Jan 23, 2024 $0.460 $0.482 $0.450 $0.467 324 786
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT